Paul Hastings
Overview
Paul Hastings received an average of $4M in total compensation, including $612K in salary, at Nkarta between 2022 and 2023. Paul Hastings also received an average of $2M at OncoMed Pharmaceuticals from 2012 to 2017.
- 2023
- 2022
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
NkartaPresident and Chief Executive Officer
NkartaPresident and Chief Executive Officer
OncoMed PharmaceuticalsFormer Chairman, Chief Executive Officer & President
OncoMed PharmaceuticalsChairman, Chief Executive Officer & President
OncoMed PharmaceuticalsChairman, Chief Executive Officer & President
OncoMed PharmaceuticalsChairman, Chief Executive Officer & President
OncoMed PharmaceuticalsChairman, Chief Executive Officer & President
OncoMed PharmaceuticalsChairman, President & Chief Executive Officer
Source: SEC filings on April 25, 2024, April 27, 2018, April 13, 2017, April 29, 2016, April 24, 2015, and April 28, 2014.
Related executives
We found 11 more executives who work or worked at Nkarta and OncoMed Pharmaceuticals.
David Shook
Nkarta
Chief Medical Officer
Alyssa Levin
Nkarta
Chief Financial and Business Officer
Paul Hastings
Nkarta
Chief Executive Officer
Alicia Hager
Nkarta
Chief Legal Officer
Nadir Mahmood
Nkarta
Chief Financial and Business Officer
Kanya Rajangam
Nkarta
Chief Medical Officer
Matthew Plunkett
Nkarta
Chief Financial Officer
John Lewicki
OncoMed Pharmaceuticals